Onyx Healthcare Inc. (TPEX:6569)
Taiwan · Delayed Price · Currency is TWD 100.50
+0.50 (0.50%)
May 8, 2026, 1:30 PM CST
Onyx Healthcare Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 145.04 | 112.13 | 180.91 | 255.26 | 202.96 | 127.55 |
Depreciation & Amortization | 22.05 | 21.81 | 20.7 | 24.1 | 26.83 | 27.04 |
Loss (Gain) From Sale of Assets | - | - | - | - | -0.25 | - |
Loss (Gain) From Sale of Investments | -7.35 | 7.7 | -9.95 | -11.86 | 12.47 | 0.92 |
Loss (Gain) on Equity Investments | -64.83 | -68.51 | -67.1 | -62.87 | -62.94 | -50.19 |
Stock-Based Compensation | 5.1 | 3.8 | 1.54 | 3.59 | 16.96 | 11.62 |
Provision & Write-off of Bad Debts | 0.36 | -1.95 | 1.76 | -0.32 | -1.35 | 0.9 |
Other Operating Activities | 51.15 | 49.07 | 16.09 | 50.51 | 66.85 | 2.39 |
Change in Accounts Receivable | -28.95 | 30.56 | 1.4 | 73.73 | -58.42 | -53.59 |
Change in Inventory | -103.03 | 17.34 | -25.18 | 65.84 | -40.31 | -91.91 |
Change in Accounts Payable | 62.1 | 24.61 | -5.8 | -37.8 | -18.17 | 28.06 |
Change in Unearned Revenue | -21.18 | -24.88 | 16.46 | -17.45 | 18.6 | 9.82 |
Change in Other Net Operating Assets | -19.72 | -7.52 | -6.37 | 7.77 | -1.42 | 4.54 |
Operating Cash Flow | 38.2 | 161.78 | 124.52 | 350.49 | 161.79 | 17.13 |
Operating Cash Flow Growth | -9.76% | 29.93% | -64.47% | 116.63% | 844.60% | -91.04% |
Capital Expenditures | -14.15 | -14.29 | -6.98 | -67.58 | -11.95 | -294.77 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.25 | 0.02 |
Sale (Purchase) of Intangibles | - | - | -0.1 | -0.4 | -3.1 | -1.13 |
Investment in Securities | -77.77 | -9.76 | -76.57 | -86.15 | -15.89 | -48.21 |
Other Investing Activities | -0.53 | -0.72 | 30.68 | -30.23 | -0.34 | 12.03 |
Investing Cash Flow | -92.46 | -24.77 | -52.98 | -184.36 | -31.03 | -332.06 |
Short-Term Debt Issued | - | 50 | 53 | 27 | - | 105 |
Long-Term Debt Issued | - | - | - | - | - | 172 |
Total Debt Issued | 70 | 50 | 53 | 27 | - | 277 |
Short-Term Debt Repaid | - | - | - | - | -105 | - |
Long-Term Debt Repaid | - | -16.94 | -14.35 | -16.37 | -19.02 | -16.95 |
Total Debt Repaid | 62.75 | -16.94 | -14.35 | -16.37 | -124.02 | -16.95 |
Net Debt Issued (Repaid) | 132.75 | 33.06 | 38.65 | 10.63 | -124.02 | 260.05 |
Issuance of Common Stock | 5.09 | 41.51 | 8.27 | 28.29 | 263.1 | - |
Common Dividends Paid | -154.52 | -154.52 | -167.58 | -166.31 | -133.05 | -151.31 |
Other Financing Activities | -7.73 | -7.73 | - | -1.15 | - | 1.15 |
Financing Cash Flow | -24.41 | -87.69 | -120.67 | -128.54 | 6.03 | 109.89 |
Foreign Exchange Rate Adjustments | -2.05 | 0.42 | 6.95 | 0.28 | 9.2 | -4.43 |
Net Cash Flow | -80.72 | 49.75 | -42.17 | 37.88 | 145.99 | -209.47 |
Free Cash Flow | 24.04 | 147.49 | 117.53 | 282.91 | 149.84 | -277.64 |
Free Cash Flow Growth | -22.84% | 25.49% | -58.46% | 88.81% | - | - |
Free Cash Flow Margin | 1.74% | 11.23% | 9.47% | 18.95% | 9.36% | -23.10% |
Free Cash Flow Per Share | 0.61 | 3.77 | 3.02 | 7.31 | 3.98 | -7.95 |
Cash Interest Paid | 4.67 | 4.67 | 4.3 | 3.68 | 3.58 | 2.58 |
Cash Income Tax Paid | 17.03 | 17.03 | 61.79 | 48.03 | 13.25 | 49.9 |
Levered Free Cash Flow | -53.03 | 73.63 | 47.6 | 165.92 | 17.56 | -322.13 |
Unlevered Free Cash Flow | -49.88 | 76.55 | 50.33 | 168.22 | 19.79 | -320.48 |
Change in Working Capital | -113.33 | 37.73 | -19.44 | 92.09 | -99.75 | -103.1 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.